Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo

Abstract Background Rapid emergence of Plasmodium resistance to anti-malarial drug mainstays has driven a continual effort to discover novel drugs that target different biochemical pathway (s) during infection. Plasma membrane Calcium + 2 ATPase (PMCA4), a novel plasma membrane protein that regulate...

Descripció completa

Dades bibliogràfiques

Autors principals:	Puji B. S. Asih, Josephine E. Siregar, Farahana K. Dewayanti, Normalita E. Pravitasari, Ismail E. Rozi, Andita F. M. Rizki, Rifqi Risandi, Kevin N. Couper, Delvac Oceandy, Din Syafruddin
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-06-01
Col·lecció:	Malaria Journal
Matèries:	PMCA4 inhibitors Antimalarial activity Plasmodium falciparum Plasmodium berghei Plasmodium yoelii In vitro and in vivo
Accés en línia:	https://doi.org/10.1186/s12936-022-04228-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!